Ocugen Inc (OCGN)
0.7300 x 9 0.7500 x 92
Pre-market by (Cboe BZX)
0.7279 +0.0202 (+2.85%) 04/29/25 [NASDAQ]
0.7300 x 9 0.7500 x 92
Pre-market 0.7300 +0.0021 (+0.29%) 04:16 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | OCGN | ANNX | ANIK | ||
| Company | Ocugen Inc | Annexon Inc | Anika Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.7100 | 1.8900 | 14.40 | ||
| High | 0.7399 | 1.9550 | 14.74 | ||
| Low | 0.6810 | 1.8500 | 14.37 | ||
| Last | 0.7279 | 1.9000 | 14.69 | ||
| Change | +0.0202 | +0.0100 | +0.18 | ||
| % Change | +2.85% | +0.53% | +1.24% | ||
| Volume | 2,728,400 | 1,020,200 | 37,500 | ||
| 20-Day Average Volume | 3,589,890 | 2,138,940 | 64,595 | ||
| Previous Close | 0.7077 | 1.8900 | 14.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.6801 | 1.6785 | 14.12 | ||
| 20-Day Raw Stochastic | 87.77% | 86.11% | 70.99% | ||
| 20-Day Relative Strength | 54.23% | 44.11% | 47.42% | ||
| Weighted Alpha | -49.01 | -74.64 | -37.73 | ||
| Today's Opinion | 24% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 40% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.49% since 04/22/25 | +7.95% since 04/22/25 | +3.49% since 04/22/25 | ||
| Low | 0.6810 on 04/29/25 | 1.7700 on 04/23/25 | 13.85 on 04/24/25 | ||
| High | 0.7499 on 04/23/25 | 1.9600 on 04/23/25 | 14.74 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -8.96% since 03/28/25 | -15.56% since 03/28/25 | -2.78% since 03/28/25 | ||
| Low | 0.5700 on 04/09/25 | 1.2800 on 04/10/25 | 12.83 on 04/09/25 | ||
| High | 0.7700 on 03/31/25 | 2.2000 on 03/31/25 | 15.45 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | -1.61% since 01/29/25 | -53.88% since 01/29/25 | -13.23% since 01/29/25 | ||
| Low | 0.5150 on 03/19/25 | 1.2800 on 04/10/25 | 12.83 on 04/09/25 | ||
| High | 0.8000 on 03/28/25 | 4.2350 on 01/30/25 | 18.37 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -24.44% since 10/29/24 | -74.90% since 10/29/24 | -40.09% since 10/29/24 | ||
| Low | 0.5150 on 03/19/25 | 1.2800 on 04/10/25 | 12.83 on 04/09/25 | ||
| High | 1.1300 on 11/08/24 | 7.6250 on 11/06/24 | 24.84 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 206,658 | 207,359 | 205,694 | ||
| Shares Outstanding, K | 292,014 | 109,714 | 14,176 | ||
| Annual Sales | 4,060,000 | 0 | 119,910,000 | ||
| Annual Net Income | -54,050,000 | -138,200,000 | -56,390,000 | ||
| Last Quarter Sales | 760,000 | 0 | 38,750,000 | ||
| Last Quarter Net Income | -13,880,000 | -48,590,000 | -29,920,000 | ||
| 60-Month Beta | 3.78 | 1.24 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 03/05/25 | -0.33 on 03/03/25 | -0.03 on 03/12/25 | ||
| Latest Earnings Date | 05/13/25 | 05/12/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||